Early research (Phase 1)Ended earlyNCT02961283What this trial is testingStudy of ASN003 in Subjects With Advanced Solid TumorsWho this might be right forNeoplasmsMelanomaColorectal Neoplasm+1 more Asana BioSciences 24
Testing effectiveness (Phase 2)Ended earlyNCT04894994What this trial is testingFLX475 in Combination With Ipilimumab in Advanced MelanomaWho this might be right forAdvanced Melanoma RAPT Therapeutics, Inc., a member of the GSK plc group of companies 6
Early research (Phase 1)Active Not RecruitingNCT03929029What this trial is testingNeoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced MelanomaWho this might be right forCutaneous Melanoma Dana-Farber Cancer Institute 11
Early research (Phase 1)Ended earlyNCT02012231What this trial is testingPhase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.Who this might be right forMelanomaThyroid CancerColorectal Cancer+4 more Fore Biotherapeutics 5
Not applicableNot Yet RecruitingNCT07819474What this trial is testingOptimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients WithWho this might be right forTumor Infiltrating LymphocyteCD8-PETAdvanced Melanoma M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT05688280What this trial is testingIntratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STSWho this might be right forMetastatic Solid TumorColon CancerNonsmall Cell Lung Cancer+1 more Immunophotonics, Inc. 42
Early research (Phase 1)Enrolling By InvitationNCT06941818What this trial is testingHS-IT101 Injection in the Treatment of Advanced MelanomaWho this might be right forAdvanced Melanoma Qingdao Sino-Cell Biomedicine Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT01119508What this trial is testingIpilimumab + Temozolomide in Metastatic MelanomaWho this might be right forMetastatic Melanoma M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)Ended earlyNCT02771626What this trial is testingStudy CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)Who this might be right forClear Cell Renal Cell Carcinoma (ccRCC)MelanomaNon-small Cell Lung Cancer (NSCLC) Calithera Biosciences, Inc 118
Early research (Phase 1)Study completedNCT01596140What this trial is testingVemurafenib in Combination With Everolimus or Temsirolimus With Advanced CancerWho this might be right forAdvanced CancerSolid Tumor M.D. Anderson Cancer Center 27
Early research (Phase 1)Study completedNCT03003676What this trial is testingA Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) BlockadeWho this might be right forAdvanced or Unresectable Melanoma Progressing After PD1 Blockade Targovax Oy 21
Testing effectiveness (Phase 2)Study completedNCT03815058What this trial is testingEvaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.Who this might be right forAdvanced Melanoma Genentech, Inc. 131
Testing effectiveness (Phase 2)Looking for participantsNCT05779423What this trial is testingCryoablation+Ipilimumab+Nivolumab in MelanomaWho this might be right forMetastatic MelanomaSkin Cancer Massachusetts General Hospital 37
Testing effectiveness (Phase 2)Study completedNCT02645149What this trial is testingMolecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic MelanomaWho this might be right forMelanoma Melanoma Institute Australia 216
Early research (Phase 1)Not Yet RecruitingNCT07107178What this trial is testingA Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant MelanomaWho this might be right forAdvanced MelanomaAdvanced Solid Tumor Biotroy Therapeutics 58
Testing effectiveness (Phase 2)Ended earlyNCT02978443What this trial is testingA Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With IpilimumabWho this might be right forAcral Lentiginous MelanomaMucosal Melanoma Georgetown University 14
Testing effectiveness (Phase 2)Ended earlyNCT05219578What this trial is testingRTX-224 Monotherapy in Patients With Solid TumorsWho this might be right forNon Small Cell Lung CancerCutaneous MelanomaHead and Neck Squamous Cell Carcinoma+2 more Rubius Therapeutics 7
Testing effectiveness (Phase 2)Ended earlyNCT03435640What this trial is testingREVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor MalignanciesWho this might be right forMelanomaMerkel Cell CarcinomaTriple Negative Breast Cancer+4 more Nektar Therapeutics 64
Early research (Phase 1)Study completedNCT00796991What this trial is testingDrug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, DacarbazineWho this might be right forAdvanced Melanoma Bristol-Myers Squibb 72
Testing effectiveness (Phase 2)WithdrawnNCT02812693What this trial is testingPembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/AmplificationWho this might be right forStage IIIA Skin MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma+1 more Joanne Jeter